Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
theres no halt ;) this is an otc stock with little volume sometimes thats all.
looks like someone is on to something here...
today is the buying opptortunity for those who want in/want more shares.
1 not before end of january imo
2 likely
3 likely
4 not likely
5 possible
6 maybe
7 no
i still see no proof of kal being short 7 million shares. the iiroc request came because of the sp INCREASE imo. see the pr i posted.
i wasnt there but ill fact check what u said later. no time right now.
... lets just wait and see how things play out when trial testing is announced. almost nothing and then red is my guess.
we could get news about the beginning of trial testing by the end of january.
there is no contradiction imo. it seems like but there is none.
go back to when the alpha prototype was released on march 2nd 2015 i think it was. the same will happen when they start trial testing imo.
nice open on the canadian side!
and as a member of the board i discuss with you. lol. give me a break. your argument is flawed imo.
furthermore blozf is not a hold right now. even less a buy. seemy post on the sister board.
well i simply think bthcf is the better investment at the moment. the market cap of blozf is already pretty high. the stock spiked although the trial hasnt started yet. when they start the trial i wouldnt be surprised if the stock doesnt move significantly. actually when that happens i expect it to drop. why? because theres ppl in it who want to make a profit when the trial starts. when the stock doesnt really move with trial start they will sell their shares. not all ppl of course but those who expected the stock to move with trial start. just look when the alpha version was released back in 2015. stock had moved before but not when the pr with the alpha came out. blozf is actually a dangerous hold atm imo.
bthcf is a steal. blozf will make bank in the end aswell dont get me wrong. but not as much as bthcf holders as blozf is already valued pretty high and has less potential left. furthermore faims in its miniaturized form from yost has never gone through a trial. nanose has. they are longer from a commercial product than bthcf imo. bthcf is simply the better investment atm. if i had any stake in blozf i would sell immediately and put it into bthcf.
its not about the "valuable" tech its about the working product. they might have set a prize for the trial tested product. who cares about the tech? your argument is flawed.
anyways i just repeated the $2-3 story as i wasnt the one who made that claim here. i mean think about the returns they would actually make. they bought their shares at 5 cents? i dont know exactly. 300 million for a trial tested device doesnt sound unrealistic for me. lets pull the taser example again... look at their market cap... its around a billion last time i checked and they have way more than a trial tested device...
canadian dollars imo as its a canadian company but i dont know for sure as i wasnt told the $2-3 story
considering the fact that there have been trials with nanose in the past i expect bthcf to submit for fda approval with our first trial
https://clinicaltrials.gov/ct2/about-studies/glossary#primary-outcome-measure
check out those definitions:
call the company and ask geodcan...
thanks for your opinion! i have to disagree though. you should make some calls and contact the company imo... they are targeting a buyout around $2-3 just like geodcan stated in the past. those who dont believe me should search the board here for his past posts.
it will take at least 3 years imo cause this is the first trial that will ever take place with the miniaturized faims device from yost for cannabix. like ive said nanose might speed up the process cause its a way more tested tech. hence it will help blozf get to market quicker after bthcf has commercialized their product using nanose.
you seem to agree though that blozf has to license nanose to get to market... bthcf is leading the way and blozf will follow. i see no problem here for both companies.
Clinical trial has started
https://clinicaltrials.gov/ct2/show/study/NCT02981550?view=results
investors slowly seem to realize that BTHCF is highly undervalued.
BTHCF Market Value $8.860.000
BLOZF Market Value $ 51.370.000
yet BTHCF has already started a trial with an advanced stage technology (NA-NOSE). BLOZF hasnt started a trial yet. furthermore FAIMS from yost is not an advanced stage technology. NA-NOSE has gone through trials in 22 different countries with thousands of patients in the past. furthermore the medical market BTHCF is aiming for is WAY larger than the market BLOZF is going for. furthermore we just got the cures act signed (see sticky). BTHCF should be valued higher or at least equal to BLOZF. BTHCF has been valued higher in the past and it will climb back up there imo.
dont get me wrong though... BLOZF will bring huge profits in the end also!
i see BTHCF getting into the $1 usd range.
thats the inventor of NA-NOSE dr. haick with bill gates. that kind of shows what kind of tech this is and what kind of ppl are interested in it... this tech will change the world imo.
yes it will be indeed. im invested heavily in the tech! with the yost team we have excellent ppl gathered who will bring this technology to market. we are almost ready for a preliminary trial. with some luck we can bring a commercial thc breathalyzer to market in 3 years. to be honest i expect a buyout for BLOZF at around $ 2-3 canadian when we have a court certified device in a few years. some ppl on the board like geodcan hava expressed the same opinion (confirmed by management). we'll make a good profit from current sp levels! it could get even better if we license the NA-NOSE tech from BTHCF/haick to BLOZF. this could speed up the process immensely as the tech is already in the clinical trial phase and has undergone trials in the past aswell (sound technology). the NA-NOSE trial at BTHCF is already in process and the primary completion date is november 2017 https://clinicaltrials.gov/ct2/show/study/NCT02981550?view=results
BTHCF is leading the way but we could profit from that immensely! things are looking very good for BLOZF!
we have the team, we will license the tech and we aim to be frist!
BLOZF long!
nice close!
another proof that faims from yost is in its infancy. nanose is years ahead and even this tech has not been commercialized yet (but will be soon, unlike faims (hint hint)).
nice to have another tech in our pockets though! never hurts and can only be our advantage.
power hour so lets go guys :)
BTHCF is highly undervalued at these prizes. looks like weve got a solid bas at 0.22 usd. just a matter of time until we move the next leg up imo.
basically the prize has been sold down to do a pp at 7.5 cents canadian. thats only my opinion. hence its no surprise we are back up there with the sp and we will continue to rise imo. the stock has been holding nicely yesterday.
the stock could easily double or triple right now.
can you believe it?! we agree on something! :)
investors slowly seem to realize that BTHCF is highly undervalued.
BTHCF Market Value $8.860.000
BLOZF Market Value $ 51.370.000
yet BTHCF has already started a trial with an advanced stage technology (NA-NOSE). BLOZF hasnt started a trial yet. furthermore FAIMS from yost is not an advanced stage technology. NA-NOSE has gone through trials in 22 different countries with thousands of patients in the past. furthermore the medical market BTHCF is aiming for is WAY larger than the market BLOZF is going for. furthermore we just got the cures act signed (see sticky). BTHCF should be valued higher or at least equal to BLOZF. BTHCF has been valued higher in the past and it will climb back up there imo.
i see BTHCF getting into the $1 usd range.
thats the inventor of NA-NOSE dr. haick with bill gates. that kind of shows what kind of tech this is and what kind of ppl are interested in it... this tech will change the world imo.
dollar land is coming for BTHCF imo.
you dont seem to understand what i am saying. i dont doubt that it will take time. it will take time no doubt! but the stock is still heavily undervalued currently and should at least be trading the market cap of blozf. pls try harder next time to actually understand what i am saying.
its a well known fact that faims from yost is in its infancy and you know that yourself. its not even closely as advanced as nanose from haick. nanose has gone through trial testing in the past while the faims protoype is not even finished yet.
thats why blozf will fail. they are years away from a commercial product and their competition is not. they wont be first to market. its a fact which some dont seem to be ready to accept. sad sad story! blind ppl!
seems like profit taking is over. time for the next leg up! dollar land were coming!
zero arguments to show that faims is advanced enough to be put into a commercial product in the not too distant future like NA-NOSE. very sad. cant you even try to bring forward a single good argument?
most of my dd lol give me a break. i do most of my dd myself. of course i profit here and there from other ppl on the board but thats a mutual thing.
faims is not advanced enough sorry. at least not when it comes to miniaturization + yost. hard to face the truth i know but blozf has no chance imo also for reasons given by medchem. i would like to see it otherwise as it will not look good for bthcf when blozf fails but they ultimately will in the end!
did so too! looks like some profit taking before we keep on going up.
we'll break 0.25 usd today imo. investors seem to realize that BTHCF is highly undervalued.
BTHCF Market Value $9,511,869
BLOZF Market Value $ 50.020.000
yet BTHCF has already started a trial with an advanced stage technology (NA-NOSE). BLOZF hasnt started a trial yet. furthermore FAIMS from yost is not an advanced stage technology. NA-NOSE has gone through trials in 22 different countries with thousands of patients in the past. furthermore the medical market BTHCF is aiming for is WAY larger than the market BLOZF is going for. furthermore we just got the cures act signed (see sticky). BTHCF should be valued higher or at least equal to BLOZF. BTHCF has been valued higher in the past and it will climb back up there.
i see BTHCF getting into the $1 usd range.
thats the inventor of NA-NOSE dr. haick with bill gates. that kind of shows what kind of tech this is and what kind of ppl are interested in it... this tech will change the world imo.
well if the news comes that the trial has started im not that sure that the sp will move siginificantly if it is still trading around 60 cents usd when the news comes out. you can go back to when the alpha version of the breathalyzer was released and everyone expected the sp would react. still nothing happened because the stock had already done its move earlier because it was apparent that the alpha would be released soon. the same thing is the case with the trial. its obvious it will start soon (beginning of february/end of january imo). hence it might already be prized in.
i just asked myself how they can have so much better energy prudction with their solar than conventional cells? tgey say their cells basically pay off in 1 year. im somewhat skeptical... ill have a look at their website